Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Kaposi Sarcoma
NCT06445166Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in Kaposi sarcoma (KS), sponsored by Washington University School of Medicine. Started Aug 2025; status: recruiting.
02
Drugs
propranolol
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT06445166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06445166.